Acute leukaemia can progress rapidly, usually requiring immediate treatment. The two most common types of acute leukaemia are acute myeloid leukaemia (AML), most often diagnosed in older people, and acute lymphoblastic leukaemia (ALL) most often diagnosed in younger people.
Both chronic lymphocytic leukaemia (CLL) and chronic myeloid leukaemia (CML) are often picked up incidentally in primary care. This is because presentation of these diseases can be gradual, with most patients with CLL diagnosed after undergoing a routine blood test.
Our courses will support you to:
Increase your awareness of the symptoms and diagnosis of acute and chronic leukaemia
Understand the different presentations, referral and management of acute and chronic leukaemia
Confidently assess the need for urgent referrals in accordance with the NICE NG12 guidelines
Appropriately safety net patients
Increase your confidence in dealing with angry patients
Find out more:
Access GatewayC’s Acute Leukaemia – Early Diagnosis course here
Access GatewayC’s Chronic Leukaemia – Early Diagnosis course here
Friday 2nd October 2020 Did you miss our free webinar on Safety Netting in Primary Care? Watch it here. Mr Malcolm Wilson, Consultant Colorectal, Peritoneal and Pelvic Oncology Surgeon and Clinical Negligence Advisor, commonly sees clinical negligence cases that...
Friday 25th September 2020 Are you seeking to improve your suspected cancer referrals? Our Improving the Quality of Your Referral course aims to assist you with this and covers: Clinical decision making Helping to reduce DNAs Key information to include in a referral...
Thursday 25th June 2020 Dr Ben Noble’s RCGP award-winning Cancer Maps is a popular interactive reference tool for GPs based on the NICE NG12 guideline; primarily, the tool is designed to be used during consultations to help clinicians assess possible cancer symptoms....
Friday 19th June 2020 For many patients, the relief of surviving their treatment or managing their condition can be followed with questions about other aspects of their life. Impotence can be very common after treatment for colorectal cancer; often affecting up to 90%...